NDC 0944-2884-06 - GLASSIA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0944-2884
- Requested NDC
- 0944-2884-06
- Package NDCs from labels
- 0944-2884-02, 0944-2884-01, 0944-2884-04, 0944-2884-03, 0944-2884-06, 0944-2884-05
- Manufacturer
- Takeda Pharmaceuticals America, Inc. | Baxalta Belgium Manufacturing SA | BAXALTA US INC. | SGS Lab Simon | Takeda Manufacturing Austria AG
- Effective date
- 2025-12-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| GLASSIA | Takeda Pharmaceuticals America, Inc. | Baxalta Belgium Manufacturing SA | BAXALTA US INC. | SGS Lab Simon | Takeda Manufacturing Austria AG | 2025-12-02 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0944-2884-01 | GLASSIA | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 31 | |
| 0944-2884-02 | GLASSIA | 50 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 50 | 31 | |
| 0944-2884-03 | GLASSIA | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 31 | |
| 0944-2884-04 | GLASSIA | 200 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 200 | 31 | |
| 0944-2884-05 | GLASSIA | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 31 | |
| 0944-2884-06 | GLASSIA | 250 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 250 | 31 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0944-2884-01 | EA - Each | 0944-2884 | 6234ccee-dced-4f84-83a1-e59f978225ba | 1 | 2012-07-24 |
| 0944-2884-02 | EA - Each | 0944-2884 | 5252d354-be53-4254-8d30-7e6e97734deb | 1 | 2019-02-13 |
| 0944-2884-03 | EA - Each | 0944-2884 | 3964a5f2-6a41-4997-9104-91a8db753820 | 1 | 2025-07-08 |
| 0944-2884-04 | EA - Each | 0944-2884 | 79eb1c4f-ccf8-4200-88b7-99d095367daf | 1 | 2025-07-08 |
| 0944-2884-05 | EA - Each | 0944-2884 | 2250c3e7-3825-480f-a70a-de809db23dd4 | 1 | 2025-07-08 |
| 0944-2884-06 | EA - Each | 0944-2884 | 30c550c7-f6c8-4996-8f2f-f4b5f3501c6b | 1 | 2025-07-08 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| .ALPHA.1-PROTEINASE INHIBITOR HUMAN | ACTIVE INGREDIENT | F43I396OIS | GLASSIA (ALPHA-1-PROTEINASE INHIBITOR (HUMAN)) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 16 | |
| .ALPHA.1-PROTEINASE INHIBITOR HUMAN | ACTIVE MOIETY | F43I396OIS | GLASSIA (ALPHA-1-PROTEINASE INHIBITOR (HUMAN)) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 16 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | GLASSIA (ALPHA-1-PROTEINASE INHIBITOR (HUMAN)) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 16 | |
| SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE | INACTIVE INGREDIENT | 5QWK665956 | GLASSIA (ALPHA-1-PROTEINASE INHIBITOR (HUMAN)) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 16 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | GLASSIA (ALPHA-1-PROTEINASE INHIBITOR (HUMAN)) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM CHLORIDE | SODIUM CHLORIDE | Hospira, Inc. | af6aebad-ef03-4d19-9a40-18e5a278b812 | 2025-11-11 | Warnings, Adverse reactions | 451W47IQ8X |
| GURUNANDA NASAL SALINE | NASAL WASH | GURUNANDA LLC | 27dbf0bf-c273-2108-e063-6394a90a0a09 | 2025-11-10 | Warnings | 451W47IQ8X |
| AZO Yeast Plus | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, AND SULFUR | i-Health, Inc. | 22845cac-8011-4ea8-b35e-b72973eddb44 | 2025-11-07 | Warnings | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Henry Schein, Inc. | 2e81ffca-05c6-4fa0-8911-4b3cbfa71351 | 2025-11-07 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Rising Pharma Holdings, Inc. | 42870188-b1d7-4934-a6c0-310530497dac | 2025-11-07 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | d8b8d796-bfba-42af-a859-99d776871558 | 2025-11-07 | Adverse reactions | 451W47IQ8X |
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Sodium Chloride | SODIUM CHLORIDE | Henry Schein, Inc. | 31188cdf-7bc8-4d78-bfaf-c1dc9f851fd4 | 2025-11-07 | Warnings, Adverse reactions | 451W47IQ8X |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | d3d29c8f-c326-4097-814a-7f4e08c67068 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | 01721071-af03-4894-95c1-10b8bc64b888 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose in Lactated Ringers | DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | 190da07e-a616-46e6-b4e5-1c0ba39306e5 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | f6d82772-638c-4584-b9d3-8833669f5963 | 2025-11-05 | Warnings, Adverse reactions | 451W47IQ8X |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula | CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, SULPHUR | TRP Company | 42b6b9b9-a673-0bba-e063-6394a90a8866 | 2025-11-03 | Warnings | 451W47IQ8X |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | ICU Medical Inc. | d8ee14e9-6733-4813-9f21-2b043a5f7188 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | ICU Medical Inc. | 4555b1bf-6d97-4798-a63d-6d34291c85ce | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Potassium Chloride in Sodium Chloride | SODIUM CHLORIDE AND POTASSIUM CHLORIDE | ICU Medical Inc. | 9dd1c001-73b3-41d4-9a96-61f6ad3a5dc3 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sodium Chloride | SODIUM CHLORIDE | ICU Medical Inc. | 3cfdeee0-ff14-4341-8396-b11c2a037c60 | 2025-11-02 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.